Eli Lilly Other Non-Current Liabilities 2012-2026 | LLY

Eli Lilly other non-current liabilities for the quarter ending March 31, 2026 were $9.845B, a 30.58% increase year-over-year.

  • Eli Lilly other non-current liabilities for 2025 were $9.845B, a 57.8% increase from 2024.
  • Eli Lilly other non-current liabilities for 2024 were $6.239B, a 2.45% increase from 2023.
  • Eli Lilly other non-current liabilities for 2023 were $6.09B, a 10.05% increase from 2022.

Eli Lilly Other Non-Current Liabilities 2012-2026 | LLY

  • Eli Lilly other non-current liabilities for 2025 were $9.845B, a 57.8% increase from 2024.
  • Eli Lilly other non-current liabilities for 2024 were $6.239B, a 2.45% increase from 2023.
  • Eli Lilly other non-current liabilities for 2023 were $6.09B, a 10.05% increase from 2022.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B